Alemtuzumab-induced lung injury in multiple sclerosis: learning from adversity in three patients
ConclusionsClinicians should be aware to early recognize acute and subacute respiratory adverse events for a promptly management. In these patients re-treatment is challenging.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Autoimmune Disease | Learning | Multiple Sclerosis | Neurology | Pneumonia | Respiratory Medicine | Steroid Therapy | Universities & Medical Training